Archives: Agenda

The landscape of clinical trials is rapidly evolving, driven by technological advancements and a shift toward patient-centric methodologies. This transition is marked by a growing emphasis on decentralization and personalized healthcare, resulting in more accessible and tailored clinical experiences for patients. Hybrid models that blend traditional site-based methods with decentralized strategies are increasingly being adopted to meet these demands and operational innovations are being developed to address the unique challenges presented by new therapeutic modalities.

This presentation will explore the profound impact of these developments on clinical trial supply chains and trial planning, highlighting how the integration of cutting-edge technologies and innovative strategies can significantly improve operational efficiency and elevate the patient experience.

Discussion topics:

• The changing clinical trial landscape and the potential for faster delivery of life-saving drugs to patients
• The role of smart technologies, deep learning, and artificial intelligence in streamlining clinical trial supply chains
• The impact of decentralized and hybrid trial models on patient accessibility and convenience
• The adoption of direct-to-patient digital capabilities and real-time track and trace systems for end-to-end visibility
• The use of AI and historical data for proactive and predictive analytics to enhance trial planning accuracy and efficiency

• Why it is so important to have proper oversight over study conduct
• How to make it smooth and effective
• Which aspects of the trial should have your special attention
• How CRO can support with keeping oversight on the proper level

• Pre-selection through identification of CDMO exclusion criteria
• Finding synergies (for the process) through cooperation with academia and suitable grants
• The RfP- how to enable the comparison of apples with apples
• The ideal process and risk assessment

• Maximizing the opportunity for strategic input and design feedback from your CRO throughout the outsourcing process
• Overview of the typical areas where your CRO can guide and facilitate study optimization
• Examples of where CRO experience has transformed study design and operations, to sponsor advantage

• Overview of current air cargo professional programs focused on specialization of temperature-controlled air cargo management
• Insights into ongoing efforts to professionalize the industry across different regions
• How training programs are integrated into audit and certification programs to airfreight operators (airlines, ground handlers, freight forwarders etc)
• Difference between regulated and non-regulated training

• In recent years, the clinical trial landscape has undergone significant transformations driven by global events, evolving trial designs, intricate supply chains, innovative dosing schemes, and a heightened focus on patient-centric approaches
• This session will present feedback from European pharma companies, offering a regional perspective on these trends and challenges. Topics discussed will explore the most impactful changes and trends shaping clinical study protocols globally.
• The session will also explore how vendor and partner relationships have adapted to these changes, highlighting key considerations for onboarding eClinical technology vendors and maintaining trust in these partnerships. An expert panel discussion will further elaborate on these topics, providing diverse viewpoints and practical strategies for navigating the evolving
  clinical trial environment.